In this interview, Marketing Manager Haris Choudhery, PhD, sat down with Head of R&D Nikolaos Ni...
Blog Posts
Learn more about our company, iPSC platform, drug discovery technologies, and exemplars of our disease models
Our phenotypic screening services help you move quickly and efficiently from screening to identifyin...
Understanding Metabolic dysfunction-associated steatotic Liver disease (MASLD) Metabolic dysfunction...
Table of Contents Understanding PFIC and PFIC2 The Challenge in Pre-Clinical Models The advantages o...
A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic-rela...
Alpha-1-antitrypsin deficiency (A1ATD) is a monogenic inherited liver disease with 180,000 individua...
Have you ever wondered how DefiniGEN’s proprietary OptiDIFF technology gives them a competitive adva...
What is the FDA Modernization Act 2.0?
The Babraham Research Campus is located on the outskirts of Cambridge, England on the site of the hi...